The main objective of the Prinses Beatrix Spierfonds is to cure muscular disease. The aim of the funding round 'Towards therapy' is to fund scientific research that is an important next step towards a targeted therapy for people with a muscle disease.In this funding round, Rick Wansink, theme Nanomedicine, and Frank Walboomers, theme Reconstructive and regenerative medicine, have been awarded a 250.000 EUR grant of the Prinses Beatrix Spierfonds towards the study and elucidation of myotonic dystrophy, in a project entitled: Harmful RNA in myotonic dystrophy.
More information (only available in Dutch): link.
Related news items
A personal touch of Antonio Castro18 October 2018
In order to promote interaction amongst colleagues within RIMLS, we have a ‘personal touch’ series setting employees in the spotlight. A light-hearted manner to learn about the colleagues you know and those you don’t! This week: Antonio Castro.read more
Mark van den Boogaard received the Dr. Peter Moleman penning18 October 2018
Last week Mark van den Boogaard received the Dr. Peter Moleman penning for best article in the field of psycho-pharmacy published in the last 2 years.read more
Symposium Medical care for people with intellectual disabilities18 October 2018
On Tuesday 4 December Esther Bakker will defend her thesis ‘A Pro-active health assessment instrument for people with intellectual disabilities – towards reducing health inequities’. Prior to her defense, a symposium will be held.read more
Very few similarities between the brains of schizophrenia patients Research at group level says little about the individual patient16 October 2018
Patients with a diagnosis of schizophrenia are a heterogenous group with large differences between individuals. Researchers at the Radboudumc showed that only a negligible number of identical features in the brain occur in more than two percent of patients.read more